The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...

The affordable pricing and simple process of direct-to-consumer DNA kits means curiosity around family and cultural heritage ...

23andMe (ME) stock nosedived over 33% yesterday after the board unanimously rejected CEO Anne Wojcicki’s takeover offer. The company has set up a Special Committee of the Board of Directors to ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and ...